SEC 13F Intelligence

5am Venture Management, LLC / VKTX

5am Venture Management, LLC’s Viking Therapeutics Inc Position

Does 5am Venture Management, LLC own Viking Therapeutics Inc (VKTX)? Not currently — the last reported position was 189.6K shares worth $5M in Q2 2025; the fund’s latest 13F (Q1 2026) no longer reports it.

Position Value
$5M
Q2 2025
Shares
189.6K
% of Portfolio
+1.93%
Quarters Held
10
position exited

Position History VKTX

Reported value by quarter
Q1 ’23: $6MQ1 ’23Q2 ’23: $9MQ3 ’23: $6MQ3 ’23Q4 ’23: $11MQ1 ’24: $19MQ1 ’24Q2 ’24: $13MQ3 ’24: $15MQ3 ’24Q4 ’24: $8MQ1 ’25: $5MQ1 ’25Q2 ’25: $5Mfilingsflow.com
QuarterSharesValue% of Portfolio
Q2 2025189.6K$5M+1.93%
Q1 2025189.6K$5M+1.73%
Q4 2024189.6K$8M+1.82%
Q3 2024237.6K$15M+3.11%
Q2 2024237.6K$13M+2.82%
Q1 2024237.6K$19M+4.36%
Q4 2023585.0K$11M+2.89%
Q3 2023585.0K$6M+1.86%
Q2 2023585.0K$9M+2.36%
Q1 2023350.0K$6M+1.49%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See 5am Venture Management, LLC’s full portfolio or all institutional holders of VKTX.